EBR:BIOS - Euronext Brussels - BE0974280126 - Common Stock - Currency: EUR
EBR:BIOS (3/7/2025, 7:00:00 PM)
0.003
0 (0%)
The current stock price of BIOS.BR is 0.003 EUR. In the past month the price decreased by -11.76%. In the past year, price decreased by -90%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
4AB.DE | ABBVIE INC | 21.07 | 346.68B | ||
1ABBV.MI | ABBVIE INC | 20.82 | 342.48B | ||
AMG.DE | AMGEN INC | 16.43 | 161.21B | ||
1AMGN.MI | AMGEN INC | 15.84 | 160.89B | ||
1GILD.MI | GILEAD SCIENCES INC | 25.67 | 135.84B | ||
GIS.DE | GILEAD SCIENCES INC | 25.39 | 134.40B | ||
VX1.DE | VERTEX PHARMACEUTICALS INC | 1667.04 | 115.58B | ||
ARGX.BR | ARGENX SE | 253.61 | 33.75B | ||
22UA.DE | BIONTECH SE-ADR | N/A | 24.36B | ||
IDP.DE | BIOGEN INC | 9.25 | 20.54B | ||
1BIIB.MI | BIOGEN INC | 8.39 | 19.21B | ||
0QF.DE | MODERNA INC | N/A | 13.19B |
BioSenic SA is a biotech company engages in the development of clinical assets . The company is headquartered in Mont-Saint-Guibert, Brabant-Wallon and currently employs 11 full-time employees. The company went IPO on 2015-02-06. The firm develops cell therapy products for the treatment and regeneration of bone tissue and bone reconstruction applications, osteonecrosis, ununited fractures, and maxillo-facial reconstruction. The company is engaged in research, enable adult stem cell isolation, expansion, and osteogenic differentiation. The Company’s therapeutic area focus is bone diseases, with extensions to joint, mainly osteoarthritis and disc degeneration. The company also provides cell therapy platform for tissue repair protection with an entirely new arsenal of various anti-inflammatory and anti-autoimmune formulations using the immunomodulatory properties of ATO/OATO (Arsenic trioxide/ Oral arsenic trioxide).
BIOSENIC SA
Rue Granbonpre 11, Batiment H (bte 24)
Mont-Saint-Guibert BRABANT-WALLON BE
Employees: 11
Company Website: http://www.bonetherapeutics.com/
Investor Relations: https://www.biosenic.com/investors
Phone: 32493097366
The current stock price of BIOS.BR is 0.003 EUR.
The exchange symbol of BIOSENIC SA is BIOS and it is listed on the Euronext Brussels exchange.
BIOS.BR stock is listed on the Euronext Brussels exchange.
BIOSENIC SA (BIOS.BR) has a market capitalization of 1.41M EUR. This makes BIOS.BR a Nano Cap stock.
BIOSENIC SA (BIOS.BR) currently has 11 employees.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
BIOS.BR does not pay a dividend.
BIOSENIC SA (BIOS.BR) will report earnings on 2025-05-26.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | N/A | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 42% to BIOS.BR. The Buy consensus is the average rating of analysts ratings from 9 analysts.